Genetic Modifications of Pigs for Organ Transplantation
Author Information
Author(s): Ali Asghar, Kurome Mayuko, Kessler Barbara, Kemter Elisabeth, Wolf Eckhard
Primary Institution: LMU Munich, Germany
Hypothesis
What genetic modifications of source pigs are essential and sufficient for cell, tissue, and organ xenotransplantation?
Conclusion
Genetically modified pigs can significantly improve the success of organ transplantation by preventing immune rejection and coagulation issues.
Supporting Evidence
- Genetically modified pigs have shown improved organ compatibility in preclinical trials.
- Elimination of xeno-antigens is crucial for preventing immune rejection.
- Transgenic expression of human proteins can mitigate coagulation issues in xenotransplants.
- Successful long-term survival of xenografts has been achieved in non-human primates.
- Multimodal deep phenotyping can help refine genetic modifications for better outcomes.
Takeaway
Scientists are changing the genes of pigs to make their organs safer for humans to use in transplants, which could help many people who need new organs.
Methodology
The study reviews various genetic modifications in pigs and their effects on xenotransplantation outcomes.
Limitations
The conclusions are based on preclinical trials and may not fully translate to human applications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website